Buscar
Mostrando ítems 1-10 de 333
Switching stable kidney transplant recipients to a generic tacrolimus Is feasible and safe, but it must be monitored
(Hindawi Publishing Corp., 2017)
Background. Tacrolimus is the primary immunosuppressive drug used in kidney transplant patients. Replacing brand name products with generics is a controversial issue that we studied after a Chilean Ministry of Health mandate ...
Switching stable kidney transplant recipients to a generic tacrolimus Is feasible and safe, but it must be monitored
(Hindawi Publishing Corp., 2017)
Background. Tacrolimus is the primary immunosuppressive drug used in kidney transplant patients. Replacing brand name products with generics is a controversial issue that we studied after a Chilean Ministry of Health mandate ...
Estimación del ahorro hospitalario con el reemplazo de inmunosupresores genéricos en trasplante renal
(Sociedad Médica Santiago, 2020)
Background: The use of narrow therapeutic index generic immunosuppressant in solid organ transplantation is controversial. Most experiences switching to these drugs have short term follow-up periods, analyze only pharmacokinetic ...
Discrete-time MPC for switched systems with applications to biomedical problems
(Cornell University, 2020-06)
Switched systems in which the manipulated control action is the time-dependingswitching signal describe many engineering problems, mainly related to biomedical applications. In such a context, to control the system means ...
Discontinuation rates following a switch from a reference to a biosimilar biologic in patients with inflammatory bowel disease: A systematic review and meta-analysisTaxas de descontinuação do tratamento após a troca de um biológico originador por um biossimilar em pacientes com doenças inflamatórias intestinais: Revisão sistemática e metanálise.
(2020-07-01)
– Background – Biologics have revolutionized the treatment of inflammatory bowel disease (IBD). However, these drugs had a significant influence on treatment-related costs, which resulted in the development of biosimilars. ...
Importance of monitoring and early switch to second generation tyrosine kinase inhibitors for the prognosis of patients with chronic myeloid leukemia with imatinib resistance or intolerance
(Associação Brasileira de Hematologia e Hemoterapia e daSociedade Brasileira de Transplante de Medula Óssea, 2011)
Imatinib mesylate was the first BCR-ABL-target agent approved for the treatment of chronic myeloid leukemia. Although most patients respond well to imatinib therapy, the literature shows that one third develops resistance ...
Importance of monitoring and early switch to second generation tyrosine kinase inhibitors for the prognosis of patients with chronic myeloid leukemia with imatinib resistance or intolerance
(Associação Brasileira de Hematologia e Hemoterapia e daSociedade Brasileira de Transplante de Medula ÓsseaBrasil, 2011)
Simultaneous analysis of five antidepressant drugs using direct injection of biofluids in a capillary restricted-access media-liquid chromatography-tandem mass spectrometry system
(ELSEVIER SCIENCE BV, 2008)
Direct analysis, with minimal sample pretreatment, of antidepressant drugs, fluoxetine, imipramine, desipramine, amitriptyline, and nortriptyline in biofluids was developed with a total run time of 8 min. The setup consists ...
Switched LPV Glucose Control in Type 1 Diabetes
(Institute of Electrical and Electronics Engineers, 2016-06)
Objective: The purpose of this paper is to regulate the blood glucose level in Type 1 Diabetes Mellitus patients with a practical and flexible procedure that can switch among a finite number of distinct controllers, depending ...